Australia Bone Grafts And Substitutes Market Size & Outlook
Related Markets
Australia bone grafts and substitutes market highlights
- The Australia bone grafts and substitutes market generated a revenue of USD 68.2 million in 2024 and is expected to reach USD 111.1 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.6% from 2025 to 2030.
- In terms of segment, allograft was the largest revenue generating material type in 2024.
- Synthetic is the most lucrative material type segment registering the fastest growth during the forecast period.
Bone grafts and substitutes market data book summary
| Market revenue in 2024 | USD 68.2 million |
| Market revenue in 2030 | USD 111.1 million |
| Growth rate | 8.6% (CAGR from 2025 to 2030) |
| Largest segment | Allograft |
| Fastest growing segment | Synthetic |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allograft, Synthetic |
| Key market players worldwide | DePuy Synthes, Baxter International Inc, NuVasive, Smith & Nephew PLC, Medtronic PLC, Orthofix Medical Inc, Zimmer Biomet Holdings Inc, Geistlich Pharma, Stryker Corp, AlloSource, TBF, OST Laboratoires, Biobank |
Other key industry trends
- In terms of revenue, Australia accounted for 2.2% of the global bone grafts and substitutes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China bone grafts and substitutes market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 160.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bone Grafts And Substitutes Market Scope
Bone Grafts And Substitutes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biobank | View profile | 11-50 | Lieusaint, Ile-de-France, France, Europe | http://www.biobank.fr/ |
| OST Laboratoires | View profile | 11-50 | Clermont-ferrand, Auvergne, France, Europe | https://ost-laboratoires.com/en/ |
| TBF | View profile | 11-50 | Walsall, Walsall, United Kingdom, Europe | https://tubebendform.co.uk |
| AlloSource | View profile | 501-1000 | Centennial, Colorado, United States, North America | https://www.allosource.org/ |
| Geistlich Pharma | View profile | 501-1000 | Princeton, New Jersey, United States, North America | http://geistlich-pharma.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Orthofix Medical Inc | View profile | 1634 | 3451 Plano Parkway, Lewisville, TX, United States, 75056 | https://www.orthofix.com |
| NuVasive | View profile | 1001-5000 | San Diego, California, United States, North America | http://www.nuvasive.com |
| DePuy Synthes | View profile | 5001-10000 | Raynham, Massachusetts, United States, North America | https://depuysynthes.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Australia bone grafts and substitutes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bone grafts and substitutes market will help companies and investors design strategic landscapes.
Allograft was the largest segment with a revenue share of 65.25% in 2024. Horizon Databook has segmented the Australia bone grafts and substitutes market based on allograft, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
The growing number of clinical trials for bone grafts is propelling market growth by confirming the effectiveness of new materials and technologies, which is leading to wider adoption and innovation in bone grafts and substitutes.
In April 2023, Bone Biologics Corporation, which specializes in creating ortho biologic products for spinal fusion markets, revealed that the Human Research Ethics Committee (HREC) approved Monash Health to be the initial site for a planned multicenter pilot clinical trial evaluating the Company’s NB1 bone graft in Australia.
This pilot study aims to assess the safety and efficacy of NB1 in 30 adult participants who will undergo transforaminal lumbar interbody fusion (TLIF) for the treatment of degenerative disc disease (DDD).
Reasons to subscribe to Australia bone grafts and substitutes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia bone grafts and substitutes market databook
-
Our clientele includes a mix of bone grafts and substitutes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia bone grafts and substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Australia bone grafts and substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia Bone Grafts And Substitutes Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
